Isolated, disseminated and circulating tumour cells in prostate cancer

被引:0
作者
David Schilling
Tilman Todenhöfer
Jörg Hennenlotter
Christian Schwentner
Tanja Fehm
Arnulf Stenzl
机构
[1] University Hospital Tübingen,Department of Urology
[2] University Hospital Tübingen,Department of Gynaecology
来源
Nature Reviews Urology | 2012年 / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In this Review, Schilling and colleagues explain the key steps of tumour cell dissemination in prostate cancer. Current methods for cell detection are described and the clinical significance of isolated, disseminated and circulating tumor cells with respect to disease prognosis is discussed.
引用
收藏
页码:448 / 463
页数:15
相关论文
共 231 条
  • [11] Ketcham AS(2002)Cancer control with radical prostatectomy alone in 1,000 consecutive patients J. Urol. 167 528-534
  • [12] Kollermann J(2006)Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene Cancer Res. 66 8959-8965
  • [13] Cheng L(2010)Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence Prostate Cancer Prostatic Dis. 13 311-315
  • [14] Hull GW(2010)Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts Br. J. Cancer 102 570-576
  • [15] Schmidt H(2008)Clinical significance of p53 alterations in surgically treated prostate cancers Mod. Pathol. 21 1371-1378
  • [16] Hawksworth D(2005)The “emigration, migration, and immigration” of prostate cancer Clin. Prostate Cancer 4 24-30
  • [17] Barwick BG(2007)New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration J. Cancer Res. Clin. Oncol. 133 687-695
  • [18] Schlomm T(2007)A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clin. Cancer Res. 13 7003-7011
  • [19] Pienta KJ(2006)The metastatic cascade in prostate cancer Surg. Oncol. 15 117-128
  • [20] Loberg R(2009)Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy Urol. Oncol. 27 180-186